← All organizations
Highest phase reached
Phase 2
First clinical trial
Jan 1, 2016Last known activity
Jan 15, 2018
Acquired by Lundbeck on Mar 16, 2018
Timeline
2010s
- Jun 1, 2012
Prexton Therapeutics— Founded
- Mar 16, 2018
Lundbeck— Acquired By
Drugs by trial phase (1 distinct, 3 trials)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (3)
- NCT03331848Lead sponsorPhase 2Jan 15, 2018
- NCT03162874Lead sponsorPhase 2Jun 22, 2017
- NCT02639221Lead sponsorPhase 1Jan 1, 2016
Details
- Founded
- Plan-les-ouates, CH Jun 1, 2012
- Last known activity
- Jan 15, 2018